Psychosocial and psychological interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis

The Lancet Psychiatry - Tập 8 - Trang 969-980 - 2021
Irene Bighelli1, Alessandro Rodolico2, Helena García-Mieres3, Gabi Pitschel-Walz1, Wulf-Peter Hansen4, Johannes Schneider-Thoma1, Spyridon Siafis1, Hui Wu1, Dongfang Wang1, Georgia Salanti5, Toshi A Furukawa6, Corrado Barbui7, Stefan Leucht1
1Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany
2Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Catania, Catania, Italy
3Etiopatogènia i tractament dels trastorns mentals greus (MERITT), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat. Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat. Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Barcelona, Spain
4BASTA-Das Bündnis für psychisch erkrankte Menschen, Munich, Germany
5Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
6Department of Health Promotion and Human Behaviour, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan
7WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy

Tài liệu tham khảo

Vos, 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019. A systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9 Bouwmans, 2015, Employment and the associated impact on quality of life in people diagnosed with schizophrenia, Neuropsychiatr Dis Treat, 11, 2125 The American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. 3rd edn. Washington DC, 2021. Schneider-Thoma J, Chalkou K, Dörries C, et al. Comparative efficacy and tolerability of 31 oral and depot antipsychotics for maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Lancet (in press). Ceraso, 2020, Maintenance treatment with antipsychotic drugs for schizophrenia, Cochrane Database Syst Rev, 8 Xia, 2011, Psychoeducation for schizophrenia, Cochrane Database Syst Rev, 6 Pharoah, 2010, Family intervention for schizophrenia, Cochrane Database Syst Rev, 12 Jones, 2018, Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia, Cochrane Database Syst Rev, 12 Ashcroft, 2018, Meta-analysis of caregiver-directed psychosocial interventions for schizophrenia, Community Ment Health J, 54, 983, 10.1007/s10597-018-0289-x Zhao, 2015, Psychoeducation (brief) for people with serious mental illness, Cochrane Database Syst Rev, 4 Jones, 2018, Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia, Cochrane Database Syst Rev, 11 Linden, 2014, Definition, assessment and rate of psychotherapy side effects, World Psychiatry, 13, 306, 10.1002/wps.20153 Rücker, 2015, Ranking treatments in frequentist network meta-analysis works without resampling methods, BMC Med Res Methodol, 15, 58, 10.1186/s12874-015-0060-8 Rhodes, 2015, Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data, J Clin Epidemiol, 68, 52, 10.1016/j.jclinepi.2014.08.012 Turner, 2015, Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis, Stat Med, 34, 984, 10.1002/sim.6381 Bighelli, 2020, Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence, BMJ Open, 10, 10.1136/bmjopen-2019-035073 Dias, 2010, Checking consistency in mixed treatment comparison meta-analysis, Stat Med, 29, 932, 10.1002/sim.3767 Higgins, 2012, Consistency and inconsistency in network meta-analysis. Concepts and models for multi-arm studies, Res Synth Methods, 3, 98, 10.1002/jrsm.1044 Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366 Chaimani, 2012, Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions, Res Synth Methods, 3, 161, 10.1002/jrsm.57 Harbord, 2006, A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints, Stat Med, 25, 3443, 10.1002/sim.2380 Nikolakopoulou, 2020, CINeMA: an approach for assessing confidence in the results of a network meta-analysis, PLoS Med, 17, 10.1371/journal.pmed.1003082 Papakonstantinou, 2020, CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis, Campbell Systematic Reviews, 16, 1, 10.1002/cl2.1080 Hutton, 2015, The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions. Checklist and explanations, Ann Intern Med, 162, 777, 10.7326/M14-2385 Leucht, 2005, What does the PANSS mean?, Schizophr Res, 79, 231, 10.1016/j.schres.2005.04.008 Rodolico Bighelli, 2018, Psychological interventions to reduce positive symptoms in schizophrenia. Systematic review and network meta-analysis, World Psychiatry, 17, 316, 10.1002/wps.20577 Marshall, 2000, Assertive community treatment for people with severe mental disorders, Cochrane Database Syst Rev, 2 Marshall, 2000, Case management for people with severe mental disorders, Cochrane Database Syst Rev, 2 Vaughan, 2014, Frequency of reporting of adverse events in randomized controlled trials of psychotherapy vs. psychopharmacotherapy, Compr Psychiatry, 55, 849, 10.1016/j.comppsych.2014.01.001